That sounds about right. This is going to be getting more and more attention as the potential for pima in other indications starts to be talked about. Schizophrenia and Alheimer's and both blockbuster indications. Pimavanserin could be the first highly significant CNS drug launch in over a decade. Shorts..you're going to get owned.